The 10 highest-cost drugs reimbursed by public drug plans in Canada in the 2021/22 fiscal year were all rare disease treatments with annual treatment costs of more than $250,000, according to a new report by the Patented Medicine Prices Review Board. It found the increased use of high-cost drugs continued to be the main factor […]
Three-quarters (74 per cent) of U.S. employers say they plan to consolidate their health benefits within the next year, according to a new survey by Summus Global Inc. The survey, which polled more than 250 employers, found that, while 86 per cent said they’re satisfied with their current health benefits offerings, they’re inundated with the management […]